STAGE IV LUNG CANCER AJCC V8
Clinical trials for STAGE IV LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated drug combo targets tough lung cancers
Disease control Not yet recruitingThis study tests a new treatment for people with advanced non-small cell lung cancer that has not responded to standard therapies. The approach combines a light-activated drug (ASP-1929) that targets and kills tumor cells with an immunotherapy (cemiplimab) that boosts the immune …
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
New drug combo aims to shrink Hard-to-Treat lung tumors
Disease control Not yet recruitingThis study tests two drugs—sacituzumab govitecan and ivonescimab—alone or together in people with advanced non-small cell lung cancer that has certain gene changes (like EGFR or ALK) and has come back after prior treatment. The goal is to see if the combination works better than …
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New radiation drug targets bone tumors with less marrow harm
Disease control Not yet recruitingThis early-stage trial tests a new version of a radiation drug (Sn-117m-DTPA) designed to target tumors that have spread to the bones from prostate, breast, or lung cancer. The drug delivers low-level radiation directly to bone tumors while being gentler on the bone marrow. The s…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New drug duo aims to reboot immune system against tough lung cancers
Disease control Not yet recruitingThis study is testing whether a new drug, SX-682, combined with an existing immunotherapy drug (atezolizumab), can help control advanced non-small cell lung cancer that has worsened after standard chemotherapy and immunotherapy. It aims to see if this combination can help the pat…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 23, 2026 12:43 UTC
-
Spinal tap could spot brain spread in lung cancer
Knowledge-focused Not yet recruitingThis study looks at whether a spinal tap (lumbar puncture) can find bits of tumor DNA in the fluid around the brain and spine. It includes 40 people with stage III or IV non-small cell lung cancer, who are at risk for brain metastases. The goal is to see if this test can help pre…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC